Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Latest News

Flatiron Health Earns Frost & Sullivan’s Visionary Innovation Leadership Award for EHR and Practice Management Systems in Oncology

NEW YORK–(BUSINESS WIRE)–Flatiron Health has been awarded Frost & Sullivan’s prestigious Oncology Visionary Innovation Leadership Award for EHR and Practice Management Systems in North America. Frost & Sullivan, an independent research firm, chose Flatiron for this award for our commitment to promoting cost-effective and patient-centric coordinated care.

@FlatironHealth Earns @Frost_Sullivan’s Innovation Award for Oncology EHR & Practice Management Systems

Tweet this

Frost & Sullivan identifies Flatiron’s OncoCloud™ suite as the nation’s best-in-class oncology software platform, helping oncology practices transition to value-based clinical and business strategies through greater system connectivity and deeper analytical insights. Through our flagship OncoEMR® product, Flatiron facilitates the transition to value-based care, including programs like the Merit-based Incentive Payment System and the Oncology Care Model. Our analytics solutions also provide up-to-date, robust, and reliable data to drive proper and timely clinical, operational, and financial decisions.

“Through Flatiron’s oncology-specific software platform, the company offers a secure, scalable, leading oncology health IT solution, promoting cost-effective, patient-centric and coordinated cancer care.” said Frost & Sullivan Research Analyst Koustav Chatterjee. “Flatiron’s evidence-based approach aligns with today’s value-driven healthcare landscape. Through its integrated oncology-specific software-as-a-service platform, the company steadily bridges the clinical practice and research gap to deliver better treatment options for improved patient outcomes.”

“It’s an honor to be recognized by Frost & Sullivan for the products and services that we have developed alongside our community oncology network,” said Brenton Fargnoli, MD, Flatiron Health’s medical director of value-based care and director of product marketing and strategy. “We know that community oncology is incredibly complex and we are laser focused on building the technology platform that providers need to succeed in the ever-changing landscape.”

Flatiron’s OncoCloud suite is built to meet the technology needs of the community oncology practice of the future: operationally efficient and prepared to thrive in a world driven by value-based care. For more information about our products and services, click here.

About Flatiron Health

Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. Our platform enables cancer researchers and care providers to learn from the experience of every patient. Currently, Flatiron partners with over 265 community cancer clinics, five major academic research centers and 14 out of the top 15 therapeutic oncology companies. Flatiron is backed by Google Ventures, First Round Capital, Roche and others.

ContactsDavid Cirilli, Flatiron Health
press@flatiron.com